Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Oxford Biomedica (OXB) Share News

LONDON BRIEFING: UK inflation in November cools off record high

14th Dec 2022 07:53

(Alliance News) - Stocks in London are set to open lower on Wednesday, ahead of a key interest rate decision by the US Federal Reserve later in the day. Read More

IN BRIEF: Oxford BioMedica appoints Frank Mathias as new CEO

22nd Nov 2022 10:15

Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy group - Appoints Frank Mathias as chief executive officer and board director, effective March 2023. Read More

Oxford BioMedica sells Windrush court facility for GBP60 million

14th Nov 2022 14:04

(Alliance News) - Oxford BioMedica PLC announced on Monday it had exchanged contracts for the sale and leaseback of its Windrush Court facility to Kadans Science Partner for GBP60 million. Read More

SMALL-CAP WINNERS & LOSERS: ME Group upgrades outlook on robust demand

14th Nov 2022 11:22

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday. Read More

LONDON BROKER RATINGS: Numis cuts Kingfisher but raises Next

11th Oct 2022 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday: Read More

SMALL-CAP WINNERS & LOSERS: Superdry swings to profit; Halfords falls

7th Oct 2022 11:04

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday. Read More

Oxford Biomedica extends Oaktree relationship with new loan facility

7th Oct 2022 10:30

(Alliance News) - Oxford Biomedica PLC on Friday said that it has completed the partial repayment and amendment of its Oaktree Capital Management LP loan facility, as it looks to extend its relationship with the US banking company further. Read More

SMALL-CAP WINNERS & LOSERS: Capita buoyed by contract win and disposal

16th Sep 2022 10:51

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday. Read More

Oxford BioMedica swings to interim loss as costs climb, revenue falls

15th Sep 2022 10:16

(Alliance News) - Oxford BioMedica PLC on Thursday reported a swing to interim loss and a decline in interim revenue. Read More

IN BRIEF: Oxford BioMedica subsidiary signs deal with new partner

14th Sep 2022 09:57

Oxford BioMedica PLC - Oxford, England-based gene and cell therapy company - Says subsidiary Oxford Biomedica Solutions LLC has signed a deal with an unnamed new partner, for an undisclosed sum. Says the deal gives the US-based, private biotechnology firm access to Oxford BioMedica Solutions's process and manufacturing platform. Read More

UK earnings, trading statements calendar - next 7 days

8th Sep 2022 16:00

Oxford BioMedica shares up as license deal signed with new US partner

7th Sep 2022 09:12

(Alliance News) - Oxford BioMedica PLC on Wednesday said it signed a license and supply agreement with an unnamed new partner. Read More

EXECUTIVE CHANGES: ReNeuron promotes CFO Catherine Isted to CEO role

1st Aug 2022 14:30

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News: Read More

SMALL-CAP WINNERS & LOSERS: Reach and Wickes sink on dark outlook

26th Jul 2022 11:12

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday. Read More

Oxford BioMedica begins new project and signs license agreement

26th Jul 2022 11:09

(Alliance News) - Oxford BioMedica PLC on Tuesday said it started a new project and signed a license and supply agreement. Read More

SMALL-CAP WINNERS & LOSERS: Made.com and Hochschild slide again

22nd Jul 2022 10:36

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday. Read More

IN BRIEF: Oxford BioMedica shares up on deal expansion in CAR-T

21st Jul 2022 11:13

Oxford BioMedica PLC - Oxford, England-based gene and cell therapy company - Expands its license and clinical supply agreement with Juno Therapeutics Inc, subsidiary of New-York based pharmaceutical industry company Bristol Myers Squibb. It says the expansion relates to the start of two new viral vector programmes for CAR-T therapies. "Oxford Biomedica will receive an undisclosed target nomination fee and potential payments upon the achievement of certain milestones," it notes. Read More

FTSE 100 Latest

Value8,774.65

Change-17.15